BTIS
INO icon

BB&T Investment Services’s Inovio Pharmaceuticals INO Stock Holding History

BB&T Investment Services’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1K Hold
29
– – ﹤0.01% 1355
2017
Q3 		$2K Hold
29
– – ﹤0.01% 1094
2017
Q2 		$3K Hold
29
– – ﹤0.01% 935
2017
Q1 		$2K Hold
29
– – ﹤0.01% 928
2016
Q4 		$2K Buy
+29
New +$2.62K ﹤0.01% 697

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BB&T Investment Services's INO Position: Q4 2017 in Review

BB&T Investment Services held its Inovio Pharmaceuticals (INO) position steady in Q4 2017 at 29 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

BB&T Investment Services first reported a position in INO in Q4 2016 and has held it in 5 quarters since. The position peaked at $3K in Q2 2017. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • BB&T Investment Services held 29 shares of Inovio Pharmaceuticals worth $1K as of Q4 2017.
  • BB&T Investment Services left its Inovio Pharmaceuticals share count unchanged in Q4 2017.
  • Inovio Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1355 holding.
  • BB&T Investment Services first reported a position in Inovio Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Inovio Pharmaceuticals position peaked at $3K in Q2 2017.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.